Mounjaro (tirzepatide) activates both GLP-1 and GIP receptors, offering a dual-pathway approach that may enhance appetite regulation and metabolic response in appropriate patients
Introduction Acute coronary syndromes (ACS), such as unstable angina pectoris (uAP), non-ST-elevated myocardial infarction (NSTEMI), and ST-elevated myocardial infarction (STEMI), and chronic coronary syndromes (CCS) replacing the term stable angina in 2019 ESC guidelines, are prevalent conditions with major contributions to morbidity and mortality ( Although recent reviews have described the role of GLP-1 RAs on cardiovascular risk in general, there is a lack of evidence synthesis on local actions of GLP-1 RAs in coronary arteries and the link of these mechanisms to coronary events ((Figure 1)
Administration: Taken orally, this form is designed to protect glutathione from digestive enzymes, enhancing absorption
Monitoring and Follow-Up Recommendations Men combining TRT and GLP-1 therapy should establish baseline labs including total and free testosterone, hemoglobin A1C, fasting glucose, lipid panel, liver function, and renal markers
No sides, just a little aroused the day after the injection, which doesn't hurt
